Literature detail

Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland.

Julia Klaus1 Marina L Meli1 Barbara Willi2 Sarah Nadeau3,4 Christian Beisel3 Tanja Stadler3,4 Eth Sars-CoV-Sequencing Team Herman Egberink5 Shan Zhao5 Hans Lutz1 Barbara Riond1 Nina Rösinger2 Hanspeter Stalder6,7 Sandra Renzullo6,7 Regina Hofmann-Lehmann1
Affiliations 7 institutions
  1. Clinical Laboratory, Vetsuisse Faculty, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
  2. Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
  3. Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  4. SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.
  5. Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The Netherlands.
  6. Institute for Virology and Immunology IVI, Sensemattstrasse 293, 3147 Mittelhäusern, Switzerland.
  7. Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
PMID 33802899 2021 Viruses eng epublish
PubMed DOI Browse context

Article

Publication summary

Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats' fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.

companion animals contamination COVID-19 domestic cat human-to-feline transmission neutralizing activity next generation sequencing One-Health SARS-CoV-2 serology Genome, Viral Animals Cat Diseases Cats COVID-19 Feces Male Phylogeny

Structured evidence records

Evidence records

3 total
1 records
Extraction confidence 0.90
Key finding

Genome sequencing of SARS-CoV-2 from a domestic cat revealed a close relationship to a human B.1.1.39 lineage sequence with a single SNP difference.

Virus
Location
Not specified
Supporting text

The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference.

Genes or proteins
whole genome
Analysis methods
next generation sequencing; phylogenetic analysis
1 records
Extraction confidence 0.90
Key finding

Serological testing detected SARS-CoV-2 S1 RBD antibodies and neutralizing activity in a domestic cat from a COVID-19-affected household, confirming infection.

Virus
Location
Not specified
Supporting text

The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay.

Method
antibody testing; neutralization assay
Sample type
serum
1 records
Extraction confidence 0.95
Key finding

SARS-CoV-2 was transmitted from humans to a domestic cat within a COVID-19-affected household in Switzerland, confirmed by RT-qPCR and viral genome sequencing closely matching a human sequence.

Virus
Location
Supporting text

This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The viral genome sequence from Cat 1 showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism difference.

Method
RT-qPCR; genome sequencing; serology; neutralizing assay
Study design
case report
Transmission direction
human-to-animal
Geographic raw
Switzerland
Country inferred
Switzerland